Drug Recall

HPS Pharmacies wish to advise that Luminarie, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a drug recall for Empovir^® vials as follows:

Empovir^® Vials
Cidofovir 375mg/5mL
ARTG 287040

This drug recall has been initiated following the identification of a manufacturing defect in the glass vial. The only affected batch is VCIA082 with an expiry date of 1st October 2019.

Please inspect your stock and quarantine all vials from the affected batch. If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.

Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.

Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Luminaire on 0424 439 936.